Your browser doesn't support javascript.
loading
Invasive Cutaneous Candidiasis, Autoimmune Hemolytic Anemia and Pancytopenia: A Challenging Scenario for Waldenström Macroglobulinemia in an Elderly Patient.
Caballero, Juan Carlos; Askari, Elham; Carrasco, Nerea; Piris, Miguel Angel; Perez de Camino, Begoña; Pardo, Laura; Cornago, Javier; Lopez-Lorenzo, Jose Luis; Llamas, Pilar; Solan, Laura.
Afiliación
  • Caballero JC; Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.
  • Askari E; Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.
  • Carrasco N; Infectious Diseases Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.
  • Piris MA; Pathology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.
  • Perez de Camino B; Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.
  • Pardo L; Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.
  • Cornago J; Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.
  • Lopez-Lorenzo JL; Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.
  • Llamas P; Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.
  • Solan L; Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain.
Biomedicines ; 11(4)2023 Mar 24.
Article en En | MEDLINE | ID: mdl-37189625
ABSTRACT
Waldenström macroglobulinemia (WM) is a slowly progressive hematologic malignancy that usually responds rapidly to treatment. Being a lymphoplasmacytoid neoplasm, it is associated with a monoclonal IgM component, which may be associated with multiple manifestations and symptoms. We report the case of a 77-year-old woman diagnosed with WM following the development of severe and sudden pancytopenia associated with a cold agglutinin syndrome. In order to treat the WM and the underlying hemolysis, treatment with rituximab, corticosteroids and cyclophosphamide was started. Despite the improvement in hemolysis parameters, pancytopenia persisted, and we started a second line with ibrutinib. During treatment the patient developed an uncommon invasive fungal infection (IFI) with bone marrow granulomatosis and myelofibrosis. This case shows an unusual clinical course with a poor hematopoietic response to treatment and a large number of intercurrent complications.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomedicines Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomedicines Año: 2023 Tipo del documento: Article País de afiliación: España